Retatrutide is a newly developed medication that acts as a strong GLP-1 receptor activator. This revolutionary approach holds significant hope for regulating type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved blood sugar control. Clinical trials have